The toxicity of methotrexate in male fertility and paternal teratogenicity

References

• Kalb RE, Strober B, Weinstein G, et al. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009;60:824–837.
   PubMed Web of Science ®Google Scholar
• Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut. 2006;55:1198–1206.
   PubMed Web of Science ®Google Scholar
• Visser K, Katchamart W, Loza E, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis. 2009;68:1086–1093.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Song M Ryu JC. Mechanisms underlying methotrexate-induced pulmonary toxicity. Expert Opin Drug Saf. 2009;8:451–458.
   PubMed Web of Science ®Google Scholar
• Morris LF, Harrod MJ, Menter MA Silverman AK. Methotrexate and reproduction in men: case report and recommendations. J Am Acad Dermatol. 1993;29:913–916.
   PubMed Web of Science ®Google Scholar
• Riccardi R, Vigersky RA, Barnes S, et al. Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. Cancer Res. 1982;42:1617–1619.
   PubMed Web of Science ®Google Scholar
• Cheng CY Mruk DD. The blood-testis barrier and its implications for male contraception. Pharmacol Rev. 2012;64:16–64.
   PubMed Web of Science ®Google Scholar
• Wong CH Cheng CY. The blood-testis barrier: its biology, regulation, and physiological role in spermatogenesis. Curr Top Dev Biol. 2005;71:263–296.
   PubMed Web of Science ®Google Scholar
• McDougal WS, Wein AJ, Kavoussi LR, et al. Campbell-Walsh urology eleventh edition review. 2nd ed. Philadelphia, PA: Elsevier; 2016.
   Google Scholar
• Montesinos MC, Desai A, Delano D, et al. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum. 2003;48:240–247.
   PubMed Web of Science ®Google Scholar
• Sukhotnik I, Nativ O, Roitburt A, et al. Methotrexate induces germ cell apoptosis and impairs spermatogenesis in a rat. Pediatr Surg Int. 2013;29:179–184.
   PubMed Web of Science ®Google Scholar
• Johnsen SG. Testicular biopsy score count–a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones. 1970;1:2–25.
   PubMedGoogle Scholar
• Klemmt L, Scialli AR. The transport of chemicals in semen. Birth Defects Res Part B, Dev Reprod Toxicol. 2005;74:119–131.
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, Tripathi DN, Vikram A, et al. Cytotoxic and genotoxic effects of methotrexate in germ cells of male Swiss mice. Mutat Res. 2008;655:59–67.
   PubMed Web of Science ®Google Scholar
• Weber-Schoendorfer C, Chambers C, Wacker E, et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol. 2014;66:1101–1110.
   PubMed Web of Science ®Google Scholar
• Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clinical Research Ed). 1985;291:1693–1697.
   PubMed Web of Science ®Google Scholar
• Thonneau P, Marchand S, Tallec A, et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988–1989). Hum Reprod. 1991;6:811–816.
   PubMed Web of Science ®Google Scholar
• Bablok L, Dziadecki W, Szymusik I, et al. Patterns of infertility in Poland – multicenter study. Neuro Endocrinol Lett. 2011;32:799–804.
   PubMed Web of Science ®Google Scholar
• Chiamchanya C, Su-angkawatin W. Study of the causes and the results of treatment in infertile couples at Thammasat Hospital between 1999–2004. J Med Assoc Thai. 2008;91:805–812.
   PubMedGoogle Scholar
• Case AM. Infertility evaluation and management. Strategies for family physicians. Can Fam Physician. 2003;49:1465–1472.
   PubMed Web of Science ®Google Scholar
• Templeton A, Fraser C, Thompson B. The epidemiology of infertility in Aberdeen. BMJ (Clin Res Ed). 1990;301:148–152.
   PubMed Web of Science ®Google Scholar
• Grunnet E, Nyfors A, Hansen KB. Studies of human semen in topical corticosteroid-treated and in methotrexate-treated psoriatics. Dermatologica. 1977;154:78–84.
   PubMedGoogle Scholar
• Suzuki T, Shibahara H, Tsunoda H, et al. Comparison of the Sperm Quality Analyzer IIC variables with the computer-aided sperm analysis estimates. Int J Androl. 2002;25:49–54.
   PubMedGoogle Scholar
• Agarwal A, Zini A, Sigman M. Is sperm DNA integrity assessment useful? J Urol. 2013;190:1645–1647.
   PubMed Web of Science ®Google Scholar
• Grunewald S, Paasch U, Glander HJ. Systemic dermatological treatment with relevance for male fertility. Journal der Deutschen Dermatologischen Gesellschaft = J Ger Soc Dermatol: JDDG. 2007;5:15–21.
   PubMedGoogle Scholar
• Dere E, Anderson LM, Hwang K, et al. Biomarkers of chemotherapy-induced testicular damage. Fertil Steril. 2013;100:1192–1202.
   PubMed Web of Science ®Google Scholar
• El-Beheiry A, El-Mansy E, Kamel N, et al. Methotrexate and fertility in men. Arch Androl. 1979;3:177–179.
   PubMed Web of Science ®Google Scholar
• Günther E. Andrologic examinations in the antimetabolite therapy of psoriasis. Dermatol Monatsschr. 1970;156:498–502.
   PubMedGoogle Scholar
• De Luca M, Ciampo E, Rossi A. Study of the seminal fluid in subjects treated with methotrexate. G Ital Dermatol Minerva Dermatol. 1971;46:247–249.
   PubMedGoogle Scholar
• Sussman A, Leonard JM. Psoriasis, methotrexate, and oligospermia. Arch Dermatol. 1980;116:215–217.
   PubMed Web of Science ®Google Scholar
• Shafik A. Intratunical injection of methotrexate for the treatment of seminoma of the testicle. Anti-Cancer Drugs. 1993;4:193–195.
   PubMed Web of Science ®Google Scholar
• Van Scott EJ, Reinertson RP. Morphologic and physiologic effects of chemotherapeutic agents in psoriasis. J Invest Dermatol. 1959;33:357–369.
   PubMed Web of Science ®Google Scholar
• Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000;18:4016–4027.
   PubMed Web of Science ®Google Scholar
• Hinkes E, Plotkin D. Reversible drug-induced sterility in a patient with acute leukemia. JAMA. 1973;223:1490–1491.
   PubMed Web of Science ®Google Scholar
• Shamberger RC, Sherins RJ, Ziegler JL, et al. Effects of postoperative adjuvant chemotherapy and radiotherapy on ovarian function in women undergoing treatment for soft tissue sarcoma. J Natl Cancer Inst. 1981;67:1213–1218.
   PubMedGoogle Scholar
• Rossato M, Foresta C. Antisperm antibodies in inflammatory bowel disease. Arch Intern Med. 2004;164:2283.
   PubMedGoogle Scholar
• Feagins LA, Kane SV. Sexual and reproductive issues for men with inflammatory bowel disease. Am J Gastroenterol. 2009;104:768–773.
   PubMed Web of Science ®Google Scholar
• Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, et al. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study. Rheumatology (Oxford). 2014;53:757–763.
   PubMed Web of Science ®Google Scholar
• Nouri HS, Azarmi Y Movahedin M. Effect of growth hormone on testicular dysfunction induced by methotrexate in rats. Andrologia. 2009;41:105–110.
   PubMed Web of Science ®Google Scholar
• Saxena AK, Dhungel S, Bhattacharya S, et al. Effect of chronic low dose of methotrexate on cellular proliferation during spermatogenesis in rats. Arch Androl. 2004;50:33–35.
   PubMed Web of Science ®Google Scholar
• Shrestha S, Dhungel S, Saxena AK, et al. Effect of methotrexate (MTX) administration on spermatogenesis: an experimental on animal model. Nepal Med Coll J: NMCJ. 2007;9:230–233.
   PubMedGoogle Scholar
• Russell LD Russell JA. Short-term morphological response of the rat testis to administration of five chemotherapeutic agents. Am J Anat. 1991;192:142–168.
   PubMedGoogle Scholar
• Freeman-Narrod M, Narrod SA. Chronic toxicity of methotrexate in mice. J Natl Cancer Inst. 1977;58:735–741.
   PubMedGoogle Scholar
• Lateef O, Shakoor N, Balk RA. Methotrexate pulmonary toxicity. Expert Opin Drug Saf. 2005;4:723–730.
   PubMedGoogle Scholar
• De Santis M, Cesari E, Cavaliere A, et al. Paternal exposure and counselling: experience of a Teratology Information Service. Reprod Toxicol (Elmsford, NY). 2008;26:42–46.
   PubMed Web of Science ®Google Scholar
• French AE, Koren G Motherisk T. Effect of methotrexate on male fertility. Can Fam Physician. 2003;49:577–578.
   PubMed Web of Science ®Google Scholar
• Beghin D, Cournot MP, Vauzelle C, et al. Paternal exposure to methotrexate and pregnancy outcomes. J Rheumatol. 2011;38:628–632.
   PubMed Web of Science ®Google Scholar
• Lee CY, Jin C, Mata AM, et al. A pilot study of paternal drug exposure: the Motherisk experience. Reprod Toxicol (Elmsford, NY). 2010;29:353–360.
   PubMed Web of Science ®Google Scholar
• Lamboglia F, D’Inca R, Oliva L, et al. Patient with severe Crohn’s disease became a father while on methotrexate and infliximab therapy. Inflamm Bowel Dis. 2009;15:648–649.
   PubMed Web of Science ®Google Scholar
• Perry WH. Methotrexate and teratogenesis. Arch Dermatol. 1983;119:874–875.
   PubMedGoogle Scholar
• Gromnica-Ihle E, Krüger K. Use of methotrexate in young patients with respect to the reproductive system. Clin Exp Rheumatol. 2010;28:S80–A84.
   PubMed Web of Science ®Google Scholar
• Cordier S. Evidence for a role of paternal exposures in developmental toxicity. Basic Clin Pharmacol Toxicol. 2008;102:176–181.
   PubMed Web of Science ®Google Scholar